Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AZYO - Aziyo Biologics Inc - Class A


Close
1.46
-0.040   -2.740%

Share volume: 9,838
Last Updated: Fri 01 Sep 2023 10:30:00 PM CEST
Biological Product (except Diagnostic) Manufacturing : -3.41%

PREVIOUS CLOSE
CHG
CHG%

$1.50
-0.04
-2.67%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
76%
Profitability 93%
Dept financing 25%
Liquidity 0%
Performance 90%
Performance
5 Days
-4.58%
1 Month
-27.36%
3 Months
-36.24%
6 Months
-64.04%
1 Year
-79.14%
2 Year
-82.62%
Key data
Stock price
$1.46
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.10 - $9.01
52 WEEK CHANGE
-$0.79
MARKET CAP 
17.427 M
YIELD 
N/A
SHARES OUTSTANDING 
11.936 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2023
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,674
AVERAGE 30 VOLUME 
$16,879
Company detail
CEO:
Region: US
Website: aziyobio.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients. our vision for aziyo is to impact healthcare as the premier partner in innovation of new solutions that realize the potential of regenerative medicine. honoring the gift from those who selfishly give the precious gift of donation to those who receive it, we are committed to honoring the lives of these brave individuals and their families everyday. whether you need a traditional bone graft, a processed osteobiologic, or a custom musculoskeletal tissue product, aziyo is committed to innovating new solutions that help fulfill the promise of regenerative medicine. at aziyo, we foster a collaborative environment where we deliver best-in-class solutions and operational excellence to our customers each and every day.

Recent news